Xu Z - Search Results

1

Sensitivity to chemotherapeutics of NSCLC cells with acquired resistance to EGFR-TKIs is mediated by T790M mutation or epithelial-mesenchymal transition.

Zhou J, Hu Q, Zhang X, Zheng J, Xie B, Xu Z, Zhang W. Zhou J, et al. Among authors: xu z. Oncol Rep. 2018 Apr;39(4):1783-1792. doi: 10.3892/or.2018.6242. Epub 2018 Feb 1. Oncol Rep. 2018. PMID: 29393480

2

Sonodynamic and photodynamic therapy in advanced breast carcinoma: a report of 3 cases.

Wang X, Zhang W, Xu Z, Luo Y, Mitchell D, Moss RW. Wang X, et al. Among authors: xu z. Integr Cancer Ther. 2009 Sep;8(3):283-7. doi: 10.1177/1534735409343693. Integr Cancer Ther. 2009. PMID: 19815599 Free article.

3

[Analysis of responses and prognostic factors in different chemotherapy regimens for metastatic nasopharyngeal carcinoma: a report of 171 cases].

Zhou J, Zhang WM, Chen H, Xie B, Zheng JH, Xu ZY, Lin JR. Zhou J, et al. Zhonghua Zhong Liu Za Zhi. 2009 Nov;31(11):867-72. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 20137355 Chinese.

4

[The retrospective analysis of different therapies on 150 elderly patients with advanced non-small cell lung cancer.].

Zheng J, Zhang W, Chen H, Xu Z, Zhou J, Xie B, Li L, Lin J. Zheng J, et al. Among authors: xu z. Zhongguo Fei Ai Za Zhi. 2009 Feb 20;12(2):122-6. doi: 10.3779/j.issn.1009-3419.2009.02.05. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20716404 Free article. Chinese.

5

Estrogen decreases anoikis of ovarian cancer cell line Caov-3 through reducing release of Bit1.

Zheng J, Zhou J, Xie X, Xie B, Lin J, Xu Z, Zhang W. Zheng J, et al. Among authors: xu z. DNA Cell Biol. 2014 Dec;33(12):847-53. doi: 10.1089/dna.2014.2453. DNA Cell Biol. 2014. PMID: 25211327

6

Long noncoding RNA CASC9.5 promotes the proliferation and metastasis of lung adenocarcinoma.

Zhou J, Xiao H, Yang X, Tian H, Xu Z, Zhong Y, Ma L, Zhang W, Qiao G, Liang J. Zhou J, et al. Among authors: xu z. Sci Rep. 2018 Jan 8;8(1):37. doi: 10.1038/s41598-017-18280-3. Sci Rep. 2018. PMID: 29311567 Free PMC article.

7

Association of menopausal status with COVID-19 outcomes: a propensity score matching analysis.

Wang XW, Hu H, Xu ZY, Zhang GK, Yu QH, Yang HL, Zheng JH. Wang XW, et al. Biol Sex Differ. 2021 Jan 29;12(1):16. doi: 10.1186/s13293-021-00363-6. Biol Sex Differ. 2021. PMID: 33514386 Free PMC article.

8

Brain Metastases Status and Immunotherapy Efficacy in Advanced Lung Cancer: A Systematic Review and Meta-Analysis.

Hu H, Xu ZY, Zhu Q, Liu X, Jiang SC, Zheng JH. Hu H, et al. Front Immunol. 2021 Jul 14;12:669398. doi: 10.3389/fimmu.2021.669398. eCollection 2021. Front Immunol. 2021. PMID: 34335570 Free PMC article.

9

OPRM1-ROS1 Fusion Detected by Next-Generation Sequencing with Circulating DNA in a Patient with EGFR Mutated Advanced NSCLC: A Case Report.

Zhang S, Xu Z, Zhang W. Zhang S, et al. Among authors: xu z. Case Rep Oncol. 2022 Jul 21;15(2):700-704. doi: 10.1159/000507980. eCollection 2022 May-Aug. Case Rep Oncol. 2022. PMID: 36157687 Free PMC article.

10

The risk of treatment-related toxicities with PD-1/PD-L1 inhibitors in patients with lung cancer.

Hu H, Zhu Q, Tang H, Zhang SC, Huang YZ, Wang YF, Xu ZY, Yang XW, Zheng JH, Guo CY. Hu H, et al. Int J Cancer. 2025 Feb 1;156(3):608-622. doi: 10.1002/ijc.35195. Epub 2024 Sep 25. Int J Cancer. 2025. PMID: 39319530

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38,763 results

Search Page

Filters